News

The study, carried out in collaboration with co-authors Dr Roberto Romero and colleagues of the NICHD, NIH, and DHHS, aimed to identify prognostic and diagnostic biomarkers of preterm

PSE said that gPROMS is developed in alignment with Procter & Gamble. gPROMS solids provides an integrated drag and drop graphical flowsheeting environment for model-based engineering and optimisation

Under a contract with US Department of Health and Human Services (HHS) Intercell has been working to develop a dose-sparing approach with potential for a single dose immunisation

The new organisation will be renamed as Daiichi Sankyo Life Science Research Center in India (RCI) and will be based in Gurgaon, India. Ranbaxy and Daiichi Sankyo said

Renvela is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Impax has filed abbreviated new drug application (ANDA) with the FDA

The agreement, that will expire on August 21, 2013, will replace the existing contract that expires on August 18, 2010. PPG’s Natrium plant manufactures chemicals, primarily chlorine and

Neurim said that the drug has already been approved by European Medicines Agency (EMA), the Australian Therapeutic Goods Administration (TGA), the Swiss Agency for Therapeutic Products (SwissMedic) and

Immunoxel is a botanical immune system modulator. It is used to avoid and combat the common cold and flu and in a number of clinics as a natural

Rivastigmine tartrate is suggested for treatment of mild to moderate Alzheimer’s dementia and mild to moderate Parkinson’s disease dementia. Caraco Pharma Rivastigmine tartrate capsules are available in 1.5mg,